Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02290899 · ClinicalTrials.gov registry record
Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder
A clinical trial, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- 30
- Enrollment target
NCT02290899 is a clinical trial that has completed, run by Rhode Island Hospital. The registered enrollment target is 30 participants.
The verdict
NCT02290899 has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The main purpose of this study is to investigate how the brain responds to a procedure known as transcranial direct current stimulation (tDCS) and how tDCS affects performance on a behavioral task. Research suggest that this procedure leads to improvement in brain and behavioral measures of inhibitory control (controlling impulses) in healthy control participants. The investigators want to explore whether the same improvement will be seen in kids with ADHD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-06 |
| Est. Completion | 2017-08-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02290899
The ClinicalTrials.gov registry entry for NCT02290899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02290899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02290899 about?
NCT02290899 is a clinical study titled "Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder". The main purpose of this study is to investigate how the brain responds to a procedure known as transcranial direct current stimulation (tDCS) and how tDCS affects performance on a behavioral task. Research suggest that this procedure leads to improvement in brain and behavioral measures of inhibito...
What is the current status of trial NCT02290899?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-06. Estimated completion is 2017-08-07.
Who is sponsoring clinical trial NCT02290899?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.